3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Arthritis, Rheumatoid
4
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
3
Hematologic Neoplasms
3
Leukemia
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Stomach Neoplasms
1
Spondylitis, Ankylosing
1
Solid Tumors
1
Sarcoma, Kaposi
1
Respiratory Tract Infections
1
Respiratory Distress Syndrome
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumonia
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Nasopharyngeal Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Mesothelioma
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphohistiocytosis, Hemophagocytic
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Interventions
Gemcitabine
31
Cisplatin
21
pembrolizumab
8
Fluorouracil
6
Oxaliplatin
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
durvalumab
4
Taxes
4
Albumin-Bound Paclitaxel
4
pemigatinib
3
infigratinib
3
atezolizumab
3
Specimen Handling
3
Radiosurgery
3
Platinum
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Carboplatin
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
tremelimumab
2
trametinib
2
olaparib
2
ivosidenib
2
derazantinib
2
cobimetinib
2
Trastuzumab
2
Radiotherapy
2
Panitumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Cholangiocarcinoma
×
tocilizumab
×
Clear all
No trials found.